AzTrials
AzTrials

Intimate Partner Violence Against WomenIMP-ADAPsNCT03885349

Motivational Strategies in Batterer Intervention Programs for Offenders With Alcohol/Drug Abuse Problems (IMP-ADAPs)

A study testing SBIP+ ADAPs-IMP and SBIP+IMP in people with Intimate Partner Violence Against Women and Alcohol Abuse, run by University of Valencia at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Alcohol and/or drug abuse problems (ADAPs) have been consistently identified in the scientific literature as a risk factor of intimate partner violence against women (IPVAW). Around 50% of IPVAW offenders referred to batterer intervention programs (BIPs) have ADAPs. Read more about this study

Who is it for?
Ages 18 years and older, men only
What is being tested?
SBIP+ ADAPs-IMP and SBIP+IMP
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteSpain
Study dates
4 Mar 2019to 30 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Males convicted of IPV against their partner or ex-partner
  • Alcohol and/or drugs abuse problems

Who cannot join

  • No current severe psychological disorders

Trial locations and contacts

1 site in 1 country.

Elena Terreros, PhD contact

+3463030607983918

elenaterreros@gmail.com

Spain1 site, 1 recruiting
  • Faculty of Psychology

    Valencia, 46010

    Elena Terreros, PhD

    Recruiting

Other trials in Spain

About this study

Official title: Motivational Strategies in Batterer Intervention Programs for Intimate Partner Violence Offenders With Alcohol/Drug Abuse Problems: An Experimental Study

Alcohol and/or drug abuse problems (ADAPs) have been consistently identified in the scientific literature as a risk factor of intimate partner violence against women (IPVAW). Around 50% of IPVAW offenders referred to batterer intervention programs (BIPs) have ADAPs. ADAPs are also one of the main predictors of BIPs dropout. In Spain, the majority of BIPs do not fit the intervention to specific needs or characteristics of IPVAW offenders, such as those with ADAPs. The aim of this research is to assess the effectiveness of a new motivational strategy adapted to IPVAW offenders with ADAPs, aiming to increase treatment adherence and to improve BIPs outcomes. The motivational strategy will include an individualized motivational plan (IMP) developed for each participant with ADAPs (IMP-ADAPs). In these IMPs one of the main aims will be to reduce alcohol and/or drug consumption. The current study will use a randomized control trial. Participants with ADAPs will be allocated to one of two treatment conditions: experimental condition: Standard batterer intervention program (SBIP) plus individualized motivational plan focused in ADAPs (SBIP+ ADAPs-IMP), and control condition: Standard batterer intervention program plus individualized motivational plan (SBIP+IMP). Primary/final outcomes will be recidivism and ADAPs reduction. Secondary/proximal outcomes will include treatment adherence related variables, violence related attitudes and attributions, self-control and psychological adjustment. Outcome variables will be assessed at baseline, at the end of the intervention, and at six months after the intervention will be finished.

Being tested
SBIP+ ADAPs-IMP, SBIP+IMP
Keywords
Intimate partner violence, Alcohol, Drug, Batterer intervention programs
Medical subject headings
Alcoholism, Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SBIP+ ADAPs-IMPBehavioural

    Standard batterer intervention program plus Individualized Motivational Plans adapted to alcohol and/or drug abuse problems. The SBIP consist of 70 hr of a cognitive-behavioral intervention including discussion topics such as sexism, sex roles, and gender equality. The intervention phase consisted of six modules in which different intervention techniques were applied (i.e., group dynamics, roleplaying, videos, training in cognitive restructuring, emotion management skills). The IMP included a set of motivational strategies to increase treatment compliance and motivation for change and had four main strategies: (a) five individual motivational interviews, to identify IPV related personal goals and follow up their achievement (in this case, one of the goals has to be related to ADAPs); (b) three group sessions where participants share their goals; (c) therapists follow-up and reinforcement of participants' goals; and (d) use of retention techniques.

  • SBIP+IMPBehavioural

    Standard batterer intervention program plus Individualized Motivational Plans. The SBIP consist of 70 hr of a cognitive-behavioral intervention including discussion topics such as sexism, sex roles, and gender equality. The intervention phase consist of six modules in which different intervention techniques are applied (i.e., group dynamics, roleplaying, videos, training in cognitive restructuring, emotion management skills). The IMP include a set of motivational strategies to increase treatment compliance and motivation for change and has four main strategies: (a) five individual motivational interviews, to identify IPV related personal goals and follow up their achievement; (b) three group sessions where participants share their goals, explain their progress to the group, and receive feedback, support and advice from the group; (c) therapists follow-up and reinforcement of participants' goals; and (d) use of retention techniques.

Study groups in NCT03885349
Study groupRoleWhat they receive
SBIP+ ADAPs-IMPExperimentalExperimental condition: Standard batterer intervention program (SBIP) plus individualized motivational plan (IMP) focused in alcohol and/or drugs abuse problems (ADAPs).
Receives: Behavioral: SBIP+ ADAPs-IMP
SBIP+IMPActive comparatorControl condition: Standard batterer intervention program plus individualized motivational plan (SBIP+IMP)
Receives: Behavioral: SBIP+IMP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in alcohol abuse problems

    Alcohol Use Disorders Identification Test. Saunders, Aasland, Babor, De la Fuente, \& Grant, 1993. Total scale range: 0-20 (Higher values indicate worse outcome).

    Measured: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)

  2. Change in cannabis abuse problems

    Severity Dependence Scale. Gossop et al., 1995. Total scale range: 0-15 (Higher values indicate worse outcome).

    Measured: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)

  3. Change in cocaine abuse problems

    Severity Dependence Scale. Gossop et al., 1995. Total scale range: 0-15 (Higher values indicate worse outcome).

    Measured: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)

  4. Change in self-reported physical intimate partner violence against women

    Self-reported physical violence sub-scale from the Conflict Tacticts Scale. Straus, Hamby, Boney-McCoy y Sugarman, 1996. Total scale range: 0-72 (Higher values indicate worse outcome).

    Measured: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)

  5. Change in self-reported psychological intimate partner violence against women

    Self-reported psychological violence sub-scale from the Conflict Tacticts Scale. Straus, Hamby, Boney-McCoy y Sugarman, 1996. Total scale range: 0-72 (Higher values indicate worse outcome).

    Measured: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)

  6. Change in risk of recidivism

    The Spousal Assault Risk Assessment. SARA; Kropp y Hart, 2000. Total scale range: 0-40 (Higher values indicate worse outcome)

    Measured: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)

  7. Police-reported recidivism

    Ministry of Home Affairs' monitoring system for IPV. This system includes information on further incidents of violence by individuals convicted of IPV and reported by any of the institutions involved in victim protection services. Recidivism will be considered to have occurred when this information appear in the system in the 6 months after completing the intervention.

    Measured: At 18 months (follow-up)

Secondary outcomes (9)
  1. Therapeutic alliance

    Working Alliance Inventory Shortened Observer-rated version (WAI-O-S; Tichenor \& Hill, 1989). Total scale range: 0-74 (Higher values indicate better outcome)

    Measured: 4 weeks after the first session of the intervention

  2. Change in motivation

    Based on the transtheoretical model of change (Prochaska and DiClemente, 1982; Prochaska et al., 1992), therapists will rate participants' stage of change (pre-contemplation, contemplation, preparation, action, and maintenance). Total range: 1-5 (Higher values indicate better outcome).

    Measured: At baseline, at 6 months, and at 12 months (end of intervention)

  3. Change in impulsivity

    Plutchik Impulsivity Scale; Plutchnik y Van Pragg, 1989. Total scale range: 11-44 (Higher values indicate worse outcome)

    Measured: At baseline and at 12 months (end of intervention)

  4. Change in depressive symptomatology

    Spanish reduced version of the Center for Epidemiology Studies-Depression Scale; Herrero y Gracia, 2007. Total scale range: 7-28 (Higher values indicate worse outcome)

    Measured: At baseline and at 12 months (end of intervention)

  5. Change in self-esteem

    Rosenberg Self-Esteem Scale. Rosenberg, 1965. Total scale range: 10-40 (Higher values indicate better outcome)

    Measured: At baseline and at 12 months (end of intervention)

  6. Attributions of Responsibility

    Intimate Partner Violence Responsibility Atribution Scale. Lila, Oliver, Catalá-Miñana, Galiana y Gracia, 2014. Three sub-scales: responsibility attribution to the legal system (sub-scale range: 4-20), responsibility attribution to the victim (sub-scale range: 4-20), and responsibility attribution to the offender personal context (sub-scale range: 4-20). Higher values indicate worse outcome.

    Measured: At baseline and at 12 months (end of intervention)

  7. Change in perceived severity of intimate partner violence against women

    Severity Perception of Intimate Partner Violence Against Women Scale. Gracia, García y Lila (2011). Total scale range: 8-80 (Higher values indicate better outcome)

    Measured: At baseline and at 12 months (end of intervention)

  8. Change in acceptability of intimate partner violence against women

    Acceptability of Intimate Partner Violence Against Women Scale. Martín-Fernández, Gracia, Marco, Vargas, Santirso and Lila (2018). Total scale range: 0-40 (Higher values indicate worse outcome)

    Measured: At baseline and at 12 months (end of intervention)

  9. Change in benevolent sexism

    Ambivalent Sexism Inventory. Glick y Fiske, 1996. Two sub-scales: Benevolent sexism (sub-scale range: 0-55) and Hostile sexism (sub-scale range: 0-55). Higher values indicate worse outcome

    Measured: At baseline and at 12 months (end of intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2019
  2. Study start4 Mar 2019
  3. Primary completion30 Nov 2025 (estimated)
  4. Study completion30 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03885349
Sponsor's protocol ID
H1537520365110
Acronym
IMP-ADAPs
Status last verified
Dec 2023
First submitted
5 Feb 2019
Last updated
6 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing SBIP+ ADAPs-IMP and SBIP+IMP in people with Intimate Partner Violence Against Women and Alcohol Abuse, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Elena Terreros, PhD (+3463030607983918, elenaterreros@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in alcohol abuse problems (time frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2023; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in